Rheumatoid arthritis
Conditions
Interventions
conventional therapy combined with Tripterygium treatment group:none
Sponsors
Nanjing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) Diagnostic criteria: Meeting the classification criteria of the American College of Rheumatology in 1987 or the ACR/EULAR classification criteria in 2010. 2) Age range: 18 to 70 years old (including 18 and 70 years old). 3) Treatment plan: Conventional treatment; conventional treatment + Tripterygium wilfordii treatment. All treatment plans should have detailed information on drug names, dosages, frequencies, and treatment durations. 4) Informed consent: Voluntary participation in this study, with patients signing the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Patients with insufficient data quality or missing key information were excluded. 2) Patients with incomplete follow-up information were excluded. 3) Patients for whom it was difficult to fully collect syndrome data and thus unable to conduct syndrome stratification. 4) Patients with a history of allergy to study drugs such as Tripterygium wilfordii. 5) Patients with severe cardiovascular and cerebrovascular diseases, liver and kidney diseases, malignant tumors, mental disorders; pregnant or lactating women. 6) Patients with other rheumatic immune diseases that may affect the distribution of monocyte subtypes or the assessment of RA conditions. 7) Patients who participated in other clinical trials within the previous 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DAS28 score;ACR20-50-70; | — |
Secondary
| Measure | Time frame |
|---|---|
| HAQ score;Patient Global Assessment;Physician Global Assessment;Joint tenderness count;Joint swelling count;Pain VAS score; | — |
Countries
China
Contacts
Public ContactZhe Feng
Nanjing University of Chinese Medicine
Outcome results
None listed